Skip to content

Three Quick Facts: Bellway, Oxford Instruments, Roquefort Therapeutics

*

Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Bellway trading update shows momentum recovering

There’s a trading update out from Bellway LON:BWY this morning, covering the February-May period. The housebuilder notes a sustained improvement in sales demand compared to the final quarter of the last financial year, although the forward order book has contracted by around 25% in number of properties and by slightly more than that in terms of gross value. Full year output remains in line with previous guidance.

#2. Oxford Instruments targeted sales approach delivers results

Oxford Instruments LON:OXIG has preliminary results out today, covering the 12 months to 31st March. On an adjusted basis, revenues are up 21%, whilst pre-tax profits have risen by more than 24%. Investors are being rewarded with a 7.7% uptick in dividends with management noting that the continued positive momentum is a result of the focus on structural growth in core markets.

#3. Roquefort Therapeutics cancer therapy tests looking promising

Roquefort Therapeutics LON:ROQ this morning advised the market that its anti-cancer mRNA therapy had delivered positive test study results at a statistically significant level. Management caution that these are early stage results but if they can be repeated in full clinical trials it has the potential to become a first in class cancer medicine.

Invest with these platforms

Hargreaves Lansdown IG Interactive Brokers Interactive Investor Charles Stanley
IG Interactive Brokers Charles Stanley

Looking for great investing ideas? Sign up to our free newsletter.

Join our UK news channel on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Admiral Markets

TMX
WisdomTree
ARK
FxPro
IG
Back To Top